COPN News

Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in Target-Area Hair Count vs Placebo; US and EU Submissions are Underway

Cosmo und Glenmark geben die Marktzulassung von Winlevi® (Clascoteron) 10 mg/g Creme zur Behandlung von Akne in 17 Ländern in Europa bekannt USA - Deutsch USA - español USA - English USA - English USA - Français

Cosmo et Glenmark annoncent l'autorisation de mise sur le marché de Winlevi® (clascotérone) 10 mg/g, crème pour le traitement de l'acné dans 17 pays d'Europe USA - Français USA - English USA - English USA - español

Cosmo y Glenmark anuncian la autorización de comercialización de Winlevi®

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe USA - English USA - English

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe